Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Pharbest Pharmaceuticals, Inc.
FDA Inspection
•Pharbest Pharmaceuticals, Inc.•September 15, 2025

Pharbest Pharmaceuticals, Inc. – FDA Inspection, Sep 15, 2025

Record Details

This FDA Inspection record concerns Pharbest Pharmaceuticals, Inc., with an inspection on September 15, 2025, issued by the New York District Office, covering human drugs.

Company
Pharbest Pharmaceuticals, Inc.
Inspection Date
September 15, 2025
Product Type
Human Drugs
Office
New York District Office
Person
  • Luxuly Abraham (Issuing Officer)
View Company Profile

ID · afc5c8ac-3931-4e96-a1c5-83d475731f84

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1278978
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

8
  1. 21 CFR 211.166(b)Adequate number of batches on stability
  2. 21 CFR 211.68(b)Computer control of master formula records
  3. 21 CFR 211.68(b)Written record not kept of program and validation data
  4. 21 CFR 211.160(b)(4)Establishment of calibration procedures
  5. 21 CFR 211.170(b)Annual visual exams of drug products
  6. 21 CFR 211.68(a)Calibration/Inspection/Checking not done
  7. 21 CFR 211.180(e)(2)Review of problem drugs
  8. 21 CFR 211.22(d)Procedures not in writing, fully followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Pharbest Pharmaceuticals, Inc.

8
DateClassificationOfficeProject area
November 10, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 3, 2021VAICenter for Food Safety and Applied NutritionFood Composition, Standards, Labeling and Econ
April 18, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 8, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 11, 2014VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Pharbest Pharmaceuticals, Inc.
  • FDA Inspection 1190336 - 2022-11-10
  • FDA Inspection 1155859 - 2021-11-03
  • FDA Inspection 1048617 - 2018-04-18
  • FDA Inspection 930773 - 2015-06-08
  • FDA Inspection 888588 - 2014-07-11

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharbest Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.